MDG1:FRA
MediGene AG
၀.၀၁၇ €
arrow_upward
+၃.၆၁%(+၀.၀၀၀၆၀) 1D
ဇွန် ၃၀, GMT+၂ ၂၂:၀၀:၀၀ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
SKHY Tracks Worst Month Since Nasdaq Debut: SK Hynix Reportedly Wants To Ship More Chip Tools To China Before Building In US
Trefis
·
ပြီးခဲ့သည့် ၃၇ မိနစ်
The 52-Week-High List: 18 S&P 500 Names On Wednesday
www.marketscreener.com
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
IPAS Indexo : INDEXO submits draft Company Description to Nasdaq Stockholm for preliminary review
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia